4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Zhengye Biotechnology Holding Limited (ZYBT) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Jilin, China with about 269 employees. Its market capitalization is roughly $82 million. In the fiscal year ended 2025-12-31, ZYBT reported CNY 116M in revenue and (CNY 70M) in net income.
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China.
Interactive charts & full statements → Open the ZYBT valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 116M | CNY 186M | CNY 212M | CNY 260M | — |
| Gross Profit | CNY 24M | CNY 91M | CNY 118M | CNY 148M | — |
| Operating Income (EBIT) | (CNY 68M) | CNY 17M | CNY 48M | CNY 66M | — |
| Net Income | (CNY 70M) | CNY 11M | CNY 32M | CNY 47M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | CNY 0M | (CNY 16M) | (CNY 40M) | (CNY 21M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 436M | CNY 493M | CNY 500M | CNY 520M | — |
| Total Liabilities | CNY 130M | CNY 141M | CNY 161M | CNY 163M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ZYBT viewer.
About TickerBase · Data methodology & sources · Privacy · Terms